Legal Presentations & Speeches

  • “Leveraging your Life Sciences Assets: Best Practices for Licensing and IP Due Diligence”
    American Conference Institute’s Life Sciences Patents Conference
    New York, NY (February 21-22, 2018)
  • “Attorney-Client Privilege, Contamination & Ethical Challenges”
    American Conference Institute’s Summit on IP Due Diligence
    New York, NY (November 2-3, 2017)
  • “How to Conduct IP Due Diligence for Life Science Transactions”
    Twenty-Eighth Annual Pharmaceutical / Chemical Patent Practice Update
    New Jersey Intellectual Property Law Association, Iselin, NJ (October 22, 2014)
  • “The Importance of IP in Protecting Drug Pipeline Value and International Patent Strategy Considerations”
    Zealand Pharma Capital Markets Day
    New York, NY (November 27, 2012)
  • “The Written Description Requirement for Biotech Inventions”
    Twenty-Fifth Annual Joint Patent Practice Seminar
    Connecticut, New Jersey, New York and Philadelphia Intellectual Property Law Associations
    New York, NY (April 30, 2009)
  • Panel: “Analyzing the Needs of a Venture Capitalist in the Company’s Due Diligence Research”
    American Conference Institute’s Pharma/Biotech IP Due Diligence
    New York, NY (January 29, 2009)
  • “Protecting Attorney-Client Privilege, Trade Secrets and Privacy Concerns During a Diligence Review”
    IP Masters Class (Ropes & Gray Public CLE Program April 8, 2008)
  • “Protecting Confidentiality, Trade Secrets and Attorney Client Privilege During a Diligence Review”
    Pharma/Biotech IP Due Diligencee — American Conference Institute
    New York, NY (January 31, 2008)
  • “Inherent Anticipation in the United States and Europe”
    New Jersey Intellectual Property Law Association
    Kenilworth, NJ (October 19, 2006)
  • “Patent Opinions: When, Why, What, Who?”
    2004 NYBA Annual Meeting
    New York, NY (March 2, 2004)
  • “Genetic Resources, Conservation Genetics, and Law”
    Conservation Genetics Symposium co-hosted by the Center for Biodiversity and Conservation of the American Museum of Natural History and the Wildlife Conservation Society
    American Museum of Natural History
    New York, NY (April 6, 2001)
  • “Utility And Enablement Issues In Claiming Protein Fragments”
    Fifteenth Annual Joint Patent Practice Seminar
    Connecticut, New Jersey, New York and Philadelphia Intellectual Property Law Associations
    Philadelphia, PA (April 20, 1999)